R M Ruggeri, B Altieri, P Razzore, F Retta, E Sperti, G Scotto, M P Brizzi, L Zumstein, A Pia, A Lania, E Lavezzi, G Nappo, A Laffi, M Albertelli, M Boschetti, I Hasballa, A Veresani, N Prinzi, S Pusceddu, S Oldani, F Nichetti, R Modica, R Minotta, A Liccardi, G Cannavale, E M Grossrubatscher, M G Tarsitano, V Zamponi, M C Zatelli, I Zanata, R Mazzilli, M Appetecchia, M V Davì, V Guarnotta, E Giannetta, A La Salvia, G Fanciulli, P Malandrino, A M Isidori, A Colao, A Faggiano
BACKGROUND: The incidence of neuroendocrine neoplasm (NEN) and related carcinoid syndrome (CaS) has increased markedly in recent decades, and women appear to be more at risk than men. As per other tumors, gender may be relevant in influencing the clinical and prognostic characteristics of NEN-associated CS. However, specific data on carcinoid syndrome (CaS) are still lacking. PURPOSE: To evaluate gender differences in clinical presentation and outcome of CaS. METHODS: Retrospective analysis of 144 CaS patients from 20 Italian high-volume centers was conducted...
October 14, 2023: Journal of Endocrinological Investigation